Your browser doesn't support javascript.
loading
Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With HER2/CEP17 Ratio <2.0 and Average HER2 Copy Number ≥4.0 and <6.0.
Hoda, Raza S; Brogi, Edi; Xu, Jin; Ventura, Katia; Ross, Dara S; Dang, Chau; Robson, Mark; Norton, Larry; Morrow, Monica; Wen, Hannah Y.
Afiliación
  • Hoda RS; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Brogi E; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Xu J; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ventura K; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ross DS; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dang C; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Robson M; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Norton L; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Morrow M; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wen HY; From the Departments of Pathology (Drs Hoda, Brogi, Xu, Ross, and Wen and Ms Ventura), Medicine (Drs Dang, Robson, and Norton), and Surgery (Dr Morrow), Memorial Sloan Kettering Cancer Center, New York, New York.
Arch Pathol Lab Med ; 144(5): 597-601, 2020 05.
Article en En | MEDLINE | ID: mdl-31647316

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Receptor ErbB-2 / Variaciones en el Número de Copia de ADN Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Arch Pathol Lab Med Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Receptor ErbB-2 / Variaciones en el Número de Copia de ADN Tipo de estudio: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Arch Pathol Lab Med Año: 2020 Tipo del documento: Article